Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1
Abstract Background Neonatal hypoxic-ischemic brain damage, characterized by tissue loss and neurologic dysfunction, is a leading cause of mortality and a devastating disease of the central nervous system. We have previously shown that vitexin has been attributed various medicinal properties and has...
Main Authors: | Wen-di Luo, Jia-wei Min, Wen-Xian Huang, Xin Wang, Yuan-yuan Peng, Song Han, Jun Yin, Wan-Hong Liu, Xiao-Hua He, Bi-Wen Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12974-018-1221-6 |
Similar Items
-
TRPV1 translocated to astrocytic membrane to promote migration and inflammatory infiltration thus promotes epilepsy after hypoxic ischemia in immature brain
by: Xin Wang, et al.
Published: (2019-11-01) -
NKCC1 Regulates Migration Ability of Glioblastoma Cells by Modulation of Actin Dynamics and Interacting with Cofilin
by: Paula Schiapparelli, et al.
Published: (2017-07-01) -
Changes in pancreatic histology, insulin secretion and oxidative status in diabetic rats following treatment with Ficus deltoidea and vitexin
by: Samsulrizal Nurdiana, et al.
Published: (2017-06-01) -
Role of NKCC1 and KCC2 in Epilepsy: From Expression to Function
by: Ru Liu, et al.
Published: (2020-01-01) -
Preparation of Vitexin Nanoparticles by Combining the Antisolvent Precipitation and High Pressure Homogenization Approaches Followed by Lyophilization for Dissolution Rate Enhancement
by: Chengbo Gu, et al.
Published: (2017-11-01)